News and Trends 8 Jun 2022
Synklino raises €29.8M to trial cytomegalovirus drug
Danish biotech Synklino has completed a Series A fundraising round that netted €29.8M ($31.8M). The company is developing drugs for the treatment of chronic viral infections, and the funding will…